229 related articles for article (PubMed ID: 28561042)
1. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.
Sinha S; Thomas D; Chan S; Gao Y; Brunen D; Torabi D; Reinisch A; Hernandez D; Chan A; Rankin EB; Bernards R; Majeti R; Dill DL
Nat Commun; 2017 May; 8():15580. PubMed ID: 28561042
[TBL] [Abstract][Full Text] [Related]
2. Mapping the landscape of synthetic lethal interactions in liver cancer.
Yang C; Guo Y; Qian R; Huang Y; Zhang L; Wang J; Huang X; Liu Z; Qin W; Wang C; Chen H; Ma X; Zhang D
Theranostics; 2021; 11(18):9038-9053. PubMed ID: 34522226
[TBL] [Abstract][Full Text] [Related]
3. SL
Liu Y; Wu M; Liu C; Li XL; Zheng J
IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
[TBL] [Abstract][Full Text] [Related]
4. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
Srihari S; Singla J; Wong L; Ragan MA
Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
[TBL] [Abstract][Full Text] [Related]
5. Computational Prediction of Synthetic Lethals in Genome-Scale Metabolic Models Using Fast-SL.
Raman K; Pratapa A; Mohite O; Balachandran S
Methods Mol Biol; 2018; 1716():315-336. PubMed ID: 29222760
[TBL] [Abstract][Full Text] [Related]
6. SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets.
Guo J; Liu H; Zheng J
Nucleic Acids Res; 2016 Jan; 44(D1):D1011-7. PubMed ID: 26516187
[TBL] [Abstract][Full Text] [Related]
7. Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality.
Jerby-Arnon L; Pfetzer N; Waldman YY; McGarry L; James D; Shanks E; Seashore-Ludlow B; Weinstock A; Geiger T; Clemons PA; Gottlieb E; Ruppin E
Cell; 2014 Aug; 158(5):1199-1209. PubMed ID: 25171417
[TBL] [Abstract][Full Text] [Related]
8. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
[TBL] [Abstract][Full Text] [Related]
9. Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.
Srivatsa S; Montazeri H; Bianco G; Coto-Llerena M; Marinucci M; Ng CKY; Piscuoglio S; Beerenwinkel N
Nat Commun; 2022 Dec; 13(1):7748. PubMed ID: 36517508
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethals in HIV: ways to avoid drug resistance : Running title: Preventing HIV resistance.
Petitjean M; Badel A; Veitia RA; Vanet A
Biol Direct; 2015 Apr; 10():17. PubMed ID: 25888435
[TBL] [Abstract][Full Text] [Related]
11. Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cells.
Parkhitko AA; Singh A; Hsieh S; Hu Y; Binari R; Lord CJ; Hannenhalli S; Ryan CJ; Perrimon N
PLoS Genet; 2021 Feb; 17(2):e1009354. PubMed ID: 33591981
[TBL] [Abstract][Full Text] [Related]
12. Link synthetic lethality to drug sensitivity of cancer cells.
Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
[TBL] [Abstract][Full Text] [Related]
13. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
14. Identification of synthetic lethality based on a functional network by using machine learning algorithms.
Li J; Lu L; Zhang YH; Liu M; Chen L; Huang T; Cai YD
J Cell Biochem; 2019 Jan; 120(1):405-416. PubMed ID: 30125975
[TBL] [Abstract][Full Text] [Related]
15. INFERENCE OF PERSONALIZED DRUG TARGETS VIA NETWORK PROPAGATION.
Shnaps O; Perry E; Silverbush D; Sharan R
Pac Symp Biocomput; 2016; 21():156-67. PubMed ID: 26776182
[TBL] [Abstract][Full Text] [Related]
16. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Lethal Networks for Precision Oncology: Promises and Pitfalls.
Shen JP; Ideker T
J Mol Biol; 2018 Sep; 430(18 Pt A):2900-2912. PubMed ID: 29932943
[TBL] [Abstract][Full Text] [Related]
19. Harnessing synthetic lethality to predict the response to cancer treatment.
Lee JS; Das A; Jerby-Arnon L; Arafeh R; Auslander N; Davidson M; McGarry L; James D; Amzallag A; Park SG; Cheng K; Robinson W; Atias D; Stossel C; Buzhor E; Stein G; Waterfall JJ; Meltzer PS; Golan T; Hannenhalli S; Gottlieb E; Benes CH; Samuels Y; Shanks E; Ruppin E
Nat Commun; 2018 Jun; 9(1):2546. PubMed ID: 29959327
[TBL] [Abstract][Full Text] [Related]
20. A systematic analysis of the landscape of synthetic lethality-driven precision oncology.
Schäffer AA; Chung Y; Kammula AV; Ruppin E; Lee JS
Med; 2024 Jan; 5(1):73-89.e9. PubMed ID: 38218178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
